Similar articles

• Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity.

  Erol N, Gürsoy H, Sahin A, Basmak H. Erol N, et al. J Pediatr Ophthalmol Strabismus. 2010 Aug 23;47 Online:e1-4. doi: 10.3928/01913913-20100818-09. J Pediatr Ophthalmol Strabismus. 2010. PMID: 21158371
• Intravitreal bevacizumab for the treatment of retinopathy of prematurity: a case report.

  Flavahan PW, Lavy TE, Wykes W. Flavahan PW, et al. Scott Med J. 2013 Aug;58(3):130-2. doi: 10.1177/0036933013496933. Scott Med J. 2013. PMID: 23960050
• Bilateral effect of unilateral bevacizumab injection in retinopathy of prematurity.

  Karaca C, Oner AO, Mirza E, Polat OA, Sahiner M. Karaca C, et al. JAMA Ophthalmol. 2013 Aug;131(8):1099-101. doi: 10.1001/jamaophthalmol.2013.400. JAMA Ophthalmol. 2013. PMID: 23744183 No abstract available.
• Bevacizumab (avastin) for the treatment of retinopathy of prematurity.

  Beaulieu MJ. Beaulieu MJ. Neonatal Netw. 2012 Jul-Aug;31(4):242-7. Neonatal Netw. 2012. PMID: 22763251 Review. No abstract available.
• Management of retinopathy of prematurity.

  Fleck BW. Fleck BW. Arch Dis Child Fetal Neonatal Ed. 2013 Sep;98(5):F454-6. doi: 10.1136/archdischild-2013-303933. Epub 2013 Jun 27. Arch Dis Child Fetal Neonatal Ed. 2013. PMID: 23813885 Review.